Physician

Adam Christopher Aufderheide, MD

According to 2025 Medicare claims, Adam Aufderheide, MD (NPI: 1982915344) practices ophthalmology in the Medford, OR market, with the plurality of this provider's patient population coming from Jackson, OR. This provider's primary affiliated billing organization is RETINA CARE CENTER, LLC (NPI: 1568422053; TIN: 32-0020235) and primary practice location at 97504-8473.

Aufderheide's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 834 traditional Medicare patients, billed 43,560 HCPCS/CPT codes, and received $3,118,070 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 208 prescription claims across 77 beneficiaries totaling $8,613 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 14 records totaling $422. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $1,694,807 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,934,395 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,877,244 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,952,557 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,900,193 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,680,057 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,713,456 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,684,384 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,881,467 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,118,070 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158395,352$1,694,807
20169467,156$1,934,395
201786414,506$3,877,244
20181,02514,802$3,952,557
20191,14414,732$3,900,193
20201,10213,666$3,680,057
202191210,508$2,713,456
202295312,626$2,684,384
202390126,215$2,881,467
202483443,560$3,118,070

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$10K$21K2015 Drug cost: $3,071 (USD; Tot_Drug_Cst)2016 Drug cost: $5,029 (USD; Tot_Drug_Cst)2017 Drug cost: $10,707 (USD; Tot_Drug_Cst)2018 Drug cost: $12,910 (USD; Tot_Drug_Cst)2019 Drug cost: $17,260 (USD; Tot_Drug_Cst)2020 Drug cost: $19,678 (USD; Tot_Drug_Cst)2021 Drug cost: $20,714 (USD; Tot_Drug_Cst)2022 Drug cost: $19,281 (USD; Tot_Drug_Cst)2023 Drug cost: $13,813 (USD; Tot_Drug_Cst)2024 Drug cost: $8,613 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151632$3,071
20163883$5,029
201769218$10,707
201879264$12,910
201994273$17,260
2020101357$19,678
202176318$20,714
202292235$19,281
202379210$13,813
202477208$8,613

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1291,700$653
67028Injection of drug into eye2511,610$97
92014Established patient complete exam of visual system433454$83
92012Established patient problem focused exam of visual system358898$66
92134Imaging of retina7942,219$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate483,102$2,977
Ketorolac TromethamineKetorolac Tromethamine743,613$1,706
Timolol MaleateTimolol Maleate261,680$290

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$422Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Christopher Aufderheide, MD?

Tedicare shows public-source Medicare data for Adam Christopher Aufderheide, MD (NPI 1982915344), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Christopher Aufderheide, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Christopher Aufderheide, MD?

Adam Christopher Aufderheide, MD is linked to RETINA CARE CENTER, LLC (billing NPI 1568422053) in the available physician profile data.

Does Adam Christopher Aufderheide, MD have Open Payments data?

Adam Christopher Aufderheide, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.